Testing and treating patients for hepatitis c when they receive methadone treatment could be the key to meeting the global target of eliminating the disease by 2030, University of Dundee research has shown.
A University of Dundee academic is to head up the clinical trial of a wearable device that aims to reduce the growing number of fatal opioid overdoses in Scotland.